Drug General Information
Drug ID
D01PZD
Former ID
DCL000629
Drug Name
Romiplostim
Drug Type
Small molecular drug
Indication Thrombocytopenia [ICD9: 287.3, 287.4, 287.5; ICD10:D69.6, P61.0] Approved [529941], [542005]
Chemotherapy-induced thrombocytopenia; Myelodysplastic syndromes [ICD9: 238.7, 287.3, 287.4, 287.5; ICD10:D46, D69.6, P61.0] Phase 2 [536737], [542005]
Company
Amgen
Structure
Download
2D MOL

3D MOL

Formula
C15H14N2O
Canonical SMILES
CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C
InChI
1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8-
InChIKey
WUWDLXZGHZSWQZ-WQLSENKSSA-N
CAS Number
CAS 267639-76-9
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
B02BX04
Target and Pathway
Target(s) Thrombopoietin Receptor Target Info Modulator [529941]
KEGG Pathway Cytokine-cytokine receptor interaction
Jak-STAT signaling pathway
WikiPathways Platelet Aggregation (Plug Formation)
References
Ref 5299412008 FDA drug approvals. Nat Rev Drug Discov. 2009 Feb;8(2):93-6.
Ref 536737Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54.
Ref 542005(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6974).
Ref 5299412008 FDA drug approvals. Nat Rev Drug Discov. 2009 Feb;8(2):93-6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.